Active, Not Recruiting
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
NCT03393845
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Michigan State University, Breslin Cancer Center Lansing, Michigan, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- New York University Clinical Cancer Center New York, United States